Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators
- PMID: 10836145
- DOI: 10.1146/annurev.pharmtox.40.1.491
Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators
Abstract
Peroxisome proliferators (PPs) are a large class of structurally dissimilar chemicals that have diverse effects in rodents and humans. Most, if not all, of the diverse effects of PPs are mediated by three members of the nuclear receptor superfamily called peroxisome proliferator-activated receptors (PPARs). In this review, we define the molecular mechanisms of PPs, including PPAR binding specificity, alteration of gene expression through binding to DNA response elements, and cross talk with other signaling pathways. We discuss the roles of PPARs in growth promotion in rodent hepatocarcinogenesis and potential therapeutic effects, including suppression of cancer growth and inflammation.
Similar articles
-
Central role of PPARalpha in the mechanism of action of hepatocarcinogenic peroxisome proliferators.Mutat Res. 2000 Mar 17;448(2):139-51. doi: 10.1016/s0027-5107(99)00232-8. Mutat Res. 2000. PMID: 10725468 Review.
-
PPAR: a mediator of peroxisome proliferator action.Mutat Res. 1995 Dec;333(1-2):101-9. doi: 10.1016/0027-5107(95)00136-0. Mutat Res. 1995. PMID: 8538617 Review.
-
Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.Minerva Urol Nefrol. 2002 Jun;54(2):65-79. Minerva Urol Nefrol. 2002. PMID: 12185990 Review.
-
Peroxisome proliferator-activated receptor-α signaling in hepatocarcinogenesis.Subcell Biochem. 2013;69:77-99. doi: 10.1007/978-94-007-6889-5_5. Subcell Biochem. 2013. PMID: 23821144 Review.
-
Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes.Cancer Res. 2003 Sep 15;63(18):5767-80. Cancer Res. 2003. PMID: 14522898
Cited by
-
Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases.Front Pharmacol. 2022 Oct 21;13:991059. doi: 10.3389/fphar.2022.991059. eCollection 2022. Front Pharmacol. 2022. PMID: 36339586 Free PMC article. Review.
-
Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1.Biochem J. 2006 Apr 1;395(1):81-8. doi: 10.1042/BJ20050964. Biochem J. 2006. PMID: 16343055 Free PMC article.
-
Mechanisms of phthalate ester toxicity in the female reproductive system.Environ Health Perspect. 2003 Feb;111(2):139-45. doi: 10.1289/ehp.5658. Environ Health Perspect. 2003. PMID: 12573895 Free PMC article. Review.
-
Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1.Mol Cell Biol. 2001 May;21(9):3057-70. doi: 10.1128/MCB.21.9.3057-3070.2001. Mol Cell Biol. 2001. PMID: 11287611 Free PMC article.
-
PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor.Metabolism. 2010 Apr;59(4):492-501. doi: 10.1016/j.metabol.2009.07.043. Epub 2009 Oct 20. Metabolism. 2010. PMID: 19846176 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources